Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine. (2021)

First Author: Andreou AP
Attributed to:  New non-paralytic botulinum molecules for the control of pain funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s13311-020-00967-7

PubMed Identifier: 33205382

Publication URI: http://europepmc.org/abstract/MED/33205382

Type: Journal Article/Review

Volume: 18

Parent Publication: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Issue: 1

ISSN: 1878-7479